AGL - Agilon Health, Inc.
NEXT EARNINGS:
Feb 25, 2026
(in 14 days)
Price:
--
--
|
CONSENSUS:
Hold
DETAILS
|
PRICE TARGET:
$1.30
DETAILS
HIGH:
$1.50
LOW:
$1.10
MEDIAN:
$1.30
CONSENSUS:
$1.30
UPSIDE:
232.91%
Market Cap:
161.89M
Volume:
15,689,552
Avg Volume:
7,776,972
52 Week Range:
0.3866-6.08
Sector:
Healthcare
Industry:
Medical - Care Facilities
Beta:
0.07
Last Dividend:
$N/A
Exchange:
NYSE
Country:
US
Employees:
1,076
IPO Date:
2021-04-15
EPS (TTM):
-0.63
P/E Ratio:
-3.00
Revenue (TTM):
6.06B
Total Assets:
1.73B
Total Debt:
43.96M
Cash & Equiv:
193.86M
Rev Growth (5Y):
50.1%
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
-41.7%
Debt/Equity:
0.09
Track Record
Statements >| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 6.06B | 4.32B | 2.39B | 1.52B | 1.22B | 794.41M |
| Net Income | (260.15M) | (262.60M) | (106.55M) | (406.49M) | (60.05M) | (282.59M) |
| EPS | -0.63 | -0.64 | -0.26 | -1.09 | -0.16 | -0.74 |
| Total Assets | 1.73B | 1.74B | 1.70B | 1.59B | 446.36M | 402.79M |
| Total Debt | 43.96M | 52.31M | 52.57M | 59.61M | 73.21M | 77.92M |
| Cash & Equivalents | 193.86M | 114.33M | 465.30M | 1.05B | 106.80M | 123.63M |
| Operating Cash Flow | (57.78M) | (156.20M) | (130.81M) | (148.16M) | (53.20M) | (103.86M) |
| Free Cash Flow | (71.03M) | (187.01M) | (163.47M) | (161.59M) | (55.55M) | (107.77M) |
| FCF per Share | -0.17 | -0.46 | -0.40 | -0.43 | -0.14 | -0.28 |
| Book Value | 470.95M | 661.84M | 1.04B | 1.09B | (284.73M) | (232.03M) |
| Cash & ST Investments | 405.60M | 495.10M | 877.20M | 1.05B | 106.80M | 123.63M |
| ROC Equity | -0.55 | -0.40 | -0.10 | -0.37 | N/A | N/A |